Genise Binns

NPI: 1154989408
Total Payments
$10,066
2024 Payments
$5,109
Companies
22
Transactions
289

Payment Breakdown by Category

Food & Beverage$8,170 (81.2%)
Travel$1,797 (17.9%)
Education$99.50 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,170 284 81.2%
Travel and Lodging $1,797 4 17.9%
Education $99.50 1 1.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $2,122 27 $0 (2024)
Neuronetics, Inc. $1,377 5 $0 (2024)
ABBVIE INC. $990.26 46 $0 (2024)
Alkermes, Inc. $822.24 27 $0 (2024)
Teva Pharmaceuticals USA, Inc. $752.85 36 $0 (2024)
Neurocrine Biosciences, Inc. $683.95 22 $0 (2024)
ITI, Inc. $625.52 18 $0 (2023)
Otsuka America Pharmaceutical, Inc. $432.78 20 $0 (2024)
Axsome Therapeutics, Inc. $341.80 7 $0 (2024)
Vanda Pharmaceuticals Inc. $257.35 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,109 111 Janssen Pharmaceuticals, Inc ($1,509)
2023 $2,565 73 Janssen Pharmaceuticals, Inc ($491.71)
2022 $984.59 33 Alkermes, Inc. ($194.30)
2021 $1,407 72 Sunovion Pharmaceuticals Inc. ($252.57)

All Payment Transactions

289 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
12/18/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $128.87 General
Category: Psychiatry/Psychology
12/17/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $28.36 General
Category: Neuroscience
12/09/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $115.72 General
Category: SCHIZOPHRENIA
12/09/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $20.33 General
Category: Psychiatry/Psychology
12/09/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $5.16 General
Category: Psychiatry/Psychology
12/02/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.77 General
Category: NEUROSCIENCE
11/19/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $22.49 General
Category: Neuropsychiatry
11/18/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $27.50 General
Category: Psychiatry/Psychology
11/15/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $20.94 General
Category: Neuroscience
10/31/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $19.69 General
Category: NEUROSCIENCE
10/30/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.15 General
Category: NEUROSCIENCE
10/29/2024 Tris Pharma Inc Dyanavel XR (Drug) Food and Beverage In-kind items and services $19.47 General
Category: ADHD
10/29/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $2.78 General
Category: PSYCHIATRY
10/25/2024 Neuronetics, Inc. NEUROSTAR TMS THERAPY SYSTEM (Device) Food and Beverage Cash or cash equivalent $25.91 General
Category: NEUROSTAR TMS THERAPY SYSTEM
10/24/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $18.93 General
Category: CNS
10/23/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $33.97 General
Category: Neuroscience
10/10/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $21.56 General
Category: Neuropsychiatry
10/10/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $16.35 General
Category: VILOXAZINE HYDROCHLORIDE
10/09/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $24.88 General
Category: PSYCHIATRY
10/07/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $27.66 General
Category: Neuroscience
10/03/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $30.42 General
Category: PSYCHIATRY
10/03/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $5.74 General
Category: Neuropsychiatry
10/01/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $21.32 General
Category: PSYCHIATRY
10/01/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.96 General
Category: NEUROSCIENCE
09/20/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Travel and Lodging In-kind items and services $658.61 General
Category: Neuroscience

About Genise Binns

Genise Binns is a Psychiatric/Mental Health healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2019. The National Provider Identifier (NPI) number assigned to this provider is 1154989408.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Genise Binns has received a total of $10,066 in payments from pharmaceutical and medical device companies, with $5,109 received in 2024. These payments were reported across 289 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($8,170).

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Virginia Beach, VA
  • Active Since 06/02/2019
  • Last Updated 02/03/2026
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • NPI Number 1154989408

Products in Payments

  • SPRAVATO (Drug) $1,868
  • NEUROSTAR TMS THERAPY SYSTEM (Device) $1,377
  • VRAYLAR (Drug) $990.26
  • CAPLYTA (Drug) $713.09
  • INGREZZA (Drug) $662.15
  • ARISTADA (Drug) $487.87
  • Austedo XR (Drug) $413.95
  • REXULTI (Drug) $363.99
  • Auvelity (Drug) $341.80
  • LYBALVI (Drug) $334.37
  • INVEGA SUSTENNA (Drug) $253.59
  • LATUDA (Drug) $252.57
  • AUSTEDO (Drug) $206.70
  • COBENFY (Drug) $181.86
  • ABILIFY MAINTENA (Drug) $174.42
  • TRINTELLIX (Drug) $172.60
  • AZSTARYS (Drug) $145.81
  • HETLIOZ (Drug) $141.63
  • QELBREE (Drug) $140.85
  • Dyanavel XR (Drug) $120.64

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Virginia Beach